Cresco Labs enters Florida market by acquiring assets of VidaCann Ltd.
Category: #business  By Mateen Dalal  Date: 2019-03-19
  • share
  • Twitter
  • Facebook
  • LinkedIn

Cresco Labs enters Florida market by acquiring assets of VidaCann Ltd.

The purchase consideration is approx. $120m and would consist of a mixture of cash and Cresco Labs shares

Cresco would be having 21 retail dispensaries and 14 production facilities upon the closing of the transaction

U.S. based leading vertically integrated multistate cannabis operator, Cresco Labs Inc., has recently announced that the company is entering the Florida market. Apparently, this would be executed via signing of a letter agreement for acquiring the assets or ownership interests of VidaCann Ltd., one of the most advanced and largest providers of medical cannabis in Florida, and/ or its affiliated entities.

Sources familiar with the matter informed that the purchase consideration is approx. $120 million and would be consisting of a mixture of cash and Cresco Labs shares, that would be subjected to a 6 to 12 month of lock-up agreement followed by closing. This stock and proportion of cash and final purchase price would be determined and reflected in the definitive agreement.

Reportedly, Cresco Labs would have 21 retail dispensaries and 14 production facilities upon the closing of the transaction, besides having licenses for operating a sum of 51 retail dispensaries across 10 states, such as Florida, Arizona, California, Nevada, Ohio, Pennsylvania, Illinois with Massachusetts, Maryland and New York pending approval.

Charlie Bachtell, Co-founder and Chief Executive of Cresco Labs, mentioned that entering the Florida market is in line with the strategy of the company of entering markets with strong regulatory structures with outsized demand. It is a crucial milestone for Cresco Labs that largely impacts the company’s growth trajectory and would be accretive to its earnings in 2019, he said.

Bachtell added that Florida has witnessed remarkable growth in patient registration since relaunching its cannabis program in 2017 and is among the most significant markets in the nation. The company looks forward towards welcoming all of the 100 VidaCann employees to the family of Cresco Labs.

For the record, Bennett Jones is acting as the Canadian legal advisor, and Canaccord Genuity Corp. as the financial advisor to Cresco Labs.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Merck to acquire cancer drug maker Peloton Therapeutics for $1.05Bn
Merck to acquire cancer drug maker Peloton Therapeutics for $1.05Bn
By Mateen Dalal

The acquisition would help Merck strengthen its presence in the renal cell carcinoma space and support its cancer drug portfolio. U.S. pharmaceutical conglomerate, Merck & Co. Inc. has recently agreed to purchase Dallas based Peloton Therapeutic...

Ikea invests in India’s one-stop interior design platform Livspace
Ikea invests in India’s one-stop interior design platform Livspace
By Mateen Dalal

The interior design platform had raised over $70 million last year with investment from TPG Growth & Goldman Sachs. The investment is Ikea’s first such deal in India, however it isn’t the company’s dalliance in India’s ...

BioXcel unveils data from Phase 1 study of receptor agonist BXCL501
BioXcel unveils data from Phase 1 study of receptor agonist BXCL501
By Mateen Dalal

Sublingual administration of BXCL501 had achieved drug exposures that will be therapeutic for the acute treatment of agitation Reports confirm that BioXcel Therapeutics (BTI) has recently presented data from its Phase 1 pharmacokinetic (bioavailabil...